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ABSTRACT 
 
Background: TB disease is still a serious health problem. Due to the changes that occur because of 
TB infection, appears sequelae in patients with pulmonary tuberculosis. TB sequelae will have an 
impact on the patient’s life, especially to do with the degree of dyspnea and functional capacity. 
Objective: To know the relationship between degree of dyspnea   with   functional   capacity   in   
pulmonary tuberculosis sequelae patients. 
Method: The design of this study is cross-sectional observational study. Subjects were patients with 
TB who have had at least 6 months of therapy that has been declared cured by leaving sequelae in 
Dr. Sardjito Hospital and BP4 Yogyakarta in September 2013. The sample was selected based on 
the selection criteria. Statistical analysis is using One-Way ANOVA. 
Results: From the 42 patients, there were 78.6% of patients with MRC scale 0, 11.9% of patients 
with MRC scale 1, and 4.8% respectively of patients with MRC scale 2 and 3. The mean of 6-
minute walk test distance is 257.02±64.56 meters. There is a significant relationship on comparison 
of the mean of 6-minute walk test distance on each MRC scale (p = 0.028). 
Conclusion: There is a relationship between degrees of dyspnea with functional capacity in 
pulmonary tuberculosis sequelae patients. 
 
Keywords: tuberculosis sequelae, degrees of dyspnea, functional capacity 
 
ABSTRAK 
 
Latar Belakang: Penyakit TB masih menjadi masalah kesehatan yang cukup serius. Akibat perubahan-
perubahan yang terjadi karena infeksi TB maka muncul sekuele pada paru pasien TB.  Sekuele  TB  akan  
berdampak  pada kehidupan pasien, terutama hubungannya dengan derajat sesak nafas dan kapasitas fungsional. 
Tujuan: Mengetahui hubungan antara derajat sesak nafas dengan kapasitas fungsional pada pasien sekuele 
tuberkulosis paru. 
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Metode: Desain penelitian ini adalah penelitian observasional potong lintang. Subyek penelitian adalah penderita 
TB yang telah menjalani terapi minimal 6 bulan yang sudah dinyatakan sembuh dengan meninggalkan sekuele di 
RSUP Dr. Sardjito dan BP4 Yogyakarta pada bulan September 2013. Sampel dipilih berdasarkan kriteria 
seleksi. Analisis statistik menggunakan One- Way ANOVA. 
Hasil: Dari 42 pasien, terdapat 78,6% pasien dengan skala MRC 0, 11,9% pasien dengan skala MRC 1, dan 
masing-masing 4,8% pasien dengan skala MRC 2 dan 3. Rerata  jarak  tempuh  uji  jalan  6  menit  adalah 
257,02±64,56 meter. Terdapat hubungan bermakna pada perbandingan rerata jarak tempuh uji jalan 6 menit 
pada setiap skala MRC (p = 0,028). 
Kesimpulan:  Terdapat hubungan antara derajat sesak nafas dengan kapasitas pada pasien sekuele TB paru. 
 
Kata Kunci: sekuele tuberkulosis, derajat sesak nafas, kapasitas fungsional 
 
INTRODUCTION 
 
Tuberculosis (TB) caused by the bacteria 
Mycobacterium tuberculosis and usually 
infect the lungs, the consequences can be 
fatal in 5 years (approximately 50-65% of 
cases) if left untreated. Transmission is 
usually via droplets respiratoric. Mycobacteria 
included into family Mycobacteriaceae and 
the order Actinomycetales. The most 
significant pathogenic species clinically is M. 
tuberculosis. M. tuberculosis is a rod-shaped 
aerobic bacterium; do not form spores and 
acid resistant. M. tuberculosis is usually not 
visible in the gram staining. But when once it 
stains under microscope, basil will not be 
decolorized by acid alcohol, so classified as 
acid-resistant bacilli (BTA) (Longo, et al., 
2012). Transmissions of TB through 
inhalation of organisms in aerosols 
originating from coughing and sneezing 
patients with active TB and even then the 
patient speak or from exposure to 
contaminated TB patient secretions. The 
nuclei are small droplets quickly evaporating, 
and most small (diameter < 5-10 µm) could 
be in the air for several hours and can be 
reached a tract terminal respiratorius when 
inhaled. There are about 3000 of lining that is 
infectious in any cough. Transmission is 
determined by the possibility of contact with 
the TB cases, proximity and duration of 
contact, the degree of infectious cases and 
the presence on the same neighborhoods 
(Longo, et al., 2012). 
Pulmonary tuberculosis can be 
categorized into two primary and post-
primary TB. First is primary TB Occurs 
immediately after infection with tuberculous 
bacilli. Primary TB usually involves the 
middle or lower lung. The lesion formed 
after the infection (Ghon focus) is usually 
located in the pulmonary periphery and is 
accompanied by a temporary hilar or 
paratracheal lymphadenopathy that may not 
be observed through a standard Chest X-ray. 
In most cases, the lesion heals itself and 
leaves the calcified small nodules. It is called 
the Ghon complex if there is a calcified 
Ghon focus with regional lymphadenopathy. 
When bacteria from the sub pleural focus 
penetrate the pleural cavum pleural effusion 
will occur. In severe cases, the lesion enlarges 
and the center undergoes necrosis to form a 
caverna. Lymphadenopathy can suppress the 
bronchi which can cause total obstruction 
and its respiratory distal airway collapse, 
partial obstruction with wheezing with 
segment hyperinflation or lung lobe. 
Bronchiectasis may occur in lung segments 
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or lobes damaged by progressive caseating 
pneumonia. Small granulomatous lesions may 
form in many organs and lead to progressive 
local disease or meningitis (Longo, et al., 
2012). 
Second is secondary TB reactivation. 
Usually localized in the apex of the lung or 
posterior segment of the superior lobe whose 
PaO2 is high? This high PaO2 supports 
Mycobacterium growth. Quite often also 
involves the superior segment of the inferior 
lobe. The extent of pulmonary parenchymal 
involvement varies with each patient, may be 
only small infiltrate or up to a large caverna. 
When the caverna is formed, the liquid 
necrotic content enters the airway, spreading 
bronkogenically into a satellite lesion in the 
lung that can also have a caverna. The large 
number of lung segments or lobes involved 
and the fused lesions leads to caseating 
pneumonia. These lesions have spontaneous 
remissions and fibrosis, although not treated, 
but the caverna will remain. Patients with this 
chronic condition will still release a bacillus 
tuberkel capable of infecting others. Very 
large lesions can cause breathlessness or 
respiratory distress syndrome (rare) (Longo, 
et al., 2012). 
The sequelae of tuberculosis is a 
condition with many secondary 
complications after healing of TB such as 
chronic respiratory failure, cor pulmonale or 
chronic pulmonary inflammation (Machida, 
et al., 2005). Another definition also 
mentions that sequelae of tuberculosis are a 
lung disease that undergoes permanent 
deformity after the healing of tuberculosis 
(Harada, et al., 1990). Histopathological 
findings due to tuberculosis include the 
formation of granulomas kaseosa, tissue 
liquefaction, and cavity formation. When this 
happens in the lungs, many patients who 
recover from TB undergo a permanent 
anatomical change. This results in pulmonary 
residual symptoms characterized by changes 
in the bronchial and parenchymal structures, 
including bronchovascular distortion, 
bronchiectasis, emphysematous changes, and 
fibrosis (Pasipanodya, et al., 2007). 
In treated and untreated patients, 
various residual symptoms and complications 
may occur in the lungs and outside of the 
lung of the thoracic region. These residual 
symptoms can be categorized as follows: (a) 
parenchymal lesions, including tuberculoma, 
thin-walled cavities, sikatrik, end-stage lung 
damage, aspergilloma, and bronchogenic 
carcinoma; (B) respiratory lesions, including 
bronchiectasis, tracheobronchial stenosis, 
and broncholithiasis; (C) vascular lesions, 
which include pulmonary or bronchial 
arteritis and thrombosis, bronchial artery 
dilatation, and Rasmussen aneurysm; (D) 
mediastinal lesions, which include lymph 
node calcification and extranodal extension, 
esophagomediastinal fistula or 
esophagobronkial fistula, constrictive 
pericarditis, and fibrotic mediastinitis; (E) 
pleural lesions, which include chronic 
empyema, fibrothorax, bronchopleural 
fistulas, and pneumothorax; And (f) chest 
wall lesions, which include tuberculosis of 
the ribs, tuberculosis spondylitis, and 
malignancy associated with chronic empyema 
(Kim, et al., 2001). 
Shortness of breath in tuberculosis 
shortness of breath of the respiratory system 
can be caused by 3 things: respiratory 
diseases, chest wall disease, and lung 
parenchymal disease. Airway disease is 
characterized by obstruction of expiratory 
airflow, which usually causes dynamic 
hyperinflation of the lungs and chest wall. 
Patients with moderate to severe disease have 
increased resistive and elastic load (term 
related to the stiffness of the system) in 
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ventilation muscles and increased work in 
breathing. Patients with acute 
bronchoconstriction also complain of a 
tightness, which can occur even when lung 
function is still normal. These patients usually 
have hyperventilation. 
Both chest tightness and 
hyperventilation may be associated with 
stimulation of lung receptors. Chest wall 
disease that causes stiff chest wall conditions, 
or weakened ventilatory muscles, is also 
associated with increased efforts to breathe. 
Widespread pleural effusion may cause 
shortness of breath, either improving 
respiratory activity or stimulating lung 
receptor if there is associated atelectasis. 
Disease in the lung parenchyma is associated 
with increased stiffness (decreased 
compliance) of the lungs and improves 
respiratory work. In addition, unbalanced 
ventilation / perfusion ratios, and damage 
and / or thickening of the alveolar capillary 
interface may lead to hypoxemia and 
increased desire for breathing (Longo, et al., 
2012). In patients with sequelae with residual 
symptoms including parenchymal lesions, 
airway lesions, vascular lesions, mediastinal 
lesions, pleural lesions, and chest wall lesions 
will cause shortness of breath (Kim, et al., 
2001). 
Shortness of breath is the main 
symptom that occurs in patients with chronic 
respiratory illness is a general term that 
characterizes the subjective sensation of 
difficulty in breathing. Although it is an 
indefinite phenomenon generated by a 
common mechanism, shortness of breath 
consists of qualitatively different sensations 
of varying intensity and affects the patient's 
personal perception, and is closely dependent 
on several personal factors such as social and 
economic status, linguistic aspects, affective 
components -culture and prior personal 
experience (Crisafulli, et al., 2010). 
Assessment of shortness of breath is 
important as a marker of efficacy outcomes. 
But in fact, since there are difficulties in the 
measurement of symptoms, the need arises 
to translate subjective experiences into 
numerical parameters. The use of special 
tools (assessment scale) to measure shortness 
of breath makes it possible to classify the 
severity of the symptoms and the resulting 
disorders, and monitor them over time 
(Crisafulli, et al., 2010). 
The MRC scale, which is the first 
clinical scale for the determination of 
shortness of breath, is a scale of 5 points 
based on the sensation of breathing 
difficulties experienced by the patient during 
daily life activities. Patients read the scale and 
are asked to recognize their own respiratory 
fatigue levels or, as is more often the case, 
MRC can be directly administered. Level 0 is 
the lowest level of respiratory distress felt, 
and level 4 with the biggest shortness of 
breath. Levels 0 and 1 in MRC are 
considered as the scale of symptoms, and 
when symptom-generating activities are 
known, levels 2, 3, and 4 indicate an 
indication for attention to personal capacity 
and social impact. Variations from 1 point on 
a fixed scale indicate a perceived clinical 
improvement (Crisafulli, et al., 2010). 
 
Functional Capacity 
Functional capacity is the maximum 
amount of physical energy expenditure that 
can be maintained by the patient. There are 
several ways that you can evaluate objective 
functional training capacity. The most 
popular clinical exercise test in order to 
increase the complexity is stair climbing, 
6MWT, shuttle-walk test, detection of 
exercise-induced asthma, cardiac stress tests 
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(eg, Bruce protocol), and cardiopulmonary 
exercise test (American Thoracic Society, 
2002). 
In the early 1960s, Balke developed a simple 
test to evaluate functional capacity by 
measuring walking distances over a period of 
time. A 12-minute walking distance test was 
developed to evaluate the level of physical 
fitness of a healthy individual. Then found a 
6-minute walk that performed as well as a 12-
minute test, to accommodate patients with 
respiratory illnesses who were too tired from 
walking for 12 minutes. A review of the 
walking test concluded that a 6 minute walk 
test was easy to do, better tolerated, and 
more reflective of daily living activities than 
other walking tests (American Thoracic 
Society, 2002). 
A six-minute walk test (6MWT) or a 
6-minute walking test is a simple and 
practical test that requires a length of about 
100 feet, which requires no sports equipment 
or advanced training for technicians. Walking 
is an everyday activity done by everyone, but 
not in very weak patients. This test measures 
the distance of the patient that runs quickly 
on a flat and hard surface for a period of 6 
minutes (6MWD). This test globally and 
integrally evaluates the response of all the 
systems involved during exercise, including 
the pulmonary and cardiac systems, systemic 
circulation, peripheral circulation, blood, 
neuromuscular units, and muscle metabolism. 
But this test does not provide specific 
information about the function of each organ 
involved in the exercise. The 6-minute 
walking test assessed the submaximal level of 
functional capacity. The measurable variable 
in the most important 6-minute walking test 
is the six-minute walk distance (6MWD). 
Secondary measures include fatigue and 
shortness of breath (American Thoracic 
Society, 2002). 
A strong indication for a 6 minute 
walking test is to measure the response of 
medical intervention in patients with heart or 
lung disease with moderate to severe severity. 
The 6-minute walking distance test has also 
been used as a measure of the patient's 
functional status at the time, as well as the 
predictors of morbidity and mortality. 
Absolute contraindication to walking test 
6 minutes include: unstable angina during the 
previous month and myocardial infarction 
during the previous month. Relative 
contraindications include a resting heart rate 
greater than 120 per minute, systolic blood 
pressure greater than 180 mmHg, and 
diastolic blood pressure greater than 100 
mmHg. Patients with these findings should 
be referred to a physician requesting or 
supervising tests for individual clinical 
judgment and deciding on test execution. 
Results from the electrocardiogram 
performed 6 months earlier should also be 
reviewed prior to testing. Stable angina is not 
an absolute contraindication for a 6-minute 
walking test, but patients with this symptom 
should test after taking their antiangine 
medication, and nitrate drugs should be 
available for emergencies (American 
Thoracic Society, 2002). 
A 6-minute walk should be done 
indoors, along long, flat, straight, closed 
corridors with hard surfaces that are rarely 
skipped. The walking used for walking 
should be 30m in length. Therefore, a 
corridor with a distance of 100 feet is 
required. The length of the corridor should 
be marked every 3 m. The rotation point 
must be marked. The starting and ending 
lines of each round of 60m shall be marked. 
The shorter corridor causes the patient to 
take more time to reverse the direction more 
often, thus reducing the mileage (6MWD). 
Most studies use corridors as long as 30 m, 
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but some use corridors along the 20 m or 50 
m (American Thoracic Society, 2002). 
Factors that affect functional capacity are 
pulmonary disorders; such as shortness of 
breath that occurs in patient’s pulmonary TB 
can reduce functional capacity. In addition, 
there are many sources that lead to variability 
in the distance of the 6-minute walking test 
(6MWD). 
 
METHOD 
The study was conducted with an 
observational, cross-sectional study design in 
patients with pulmonary TB sequelae to see 
how the degree of breath affected the 
functional capacity. 
Target population is tuberculosis 
patients who have undergone therapy at least 
6 months who have been declared cured by 
leaving sequels seen from chest X-rays. 
Affordable populations are post-TB patients 
who come to the pulmonary clinic of Dr. 
Sardjito and BP4 Yogyakarta in September 
2013. 
The inclusion criteria for the study subjects 
were post-treatment TB patients based on 
anamnesis, physical examination, radiological 
examination (rontgent chest) in the presence 
of fibrosis, aged 18-59 years, meeting WHO 
criteria 2009, approving and signing informed 
consent. Patients have no chronic pulmonary 
chronic comorbid, silicosis, post-thoracic 
surgery, bronchial asthma, chronic heart 
failure, collagen disease, and severe chronic 
disease. 
Samples were taken by consecutive 
sampling method where every post-TB 
patient in Lung Polyclinic of Dr. Sardjito and 
BP4 Yogyakarta who met the study criteria 
was included in the study in the period in 
September 2013. The independent variable is 
the degree of shortness of breath. The 
dependent variable is functional capacity. The 
degree of shortness of breath was measured 
using an MRC breathless scale consisting of 5 
scales from 0 to 4 showing the degree of 
shortness of breath from no shortness of 
breath to severe levels. Functional capacity 
(exercise) is the maximum amount of 
physical energy that can be deployed by the 
patient. Functional capacity is measured 
using a 6-minute walking test which is a 
practical test without the use of exercise 
equipment and does not require in-depth 
training of the meter. Functional capacity 
assessment is seen from the maximum 
distance traveled in a 6-minute walking test 
on a flat, hard surface. 
Subjects who have met the selection 
criteria are educated, informed and 
performed anamnesis and physical 
examination. All subjects answered the MRC 
shortness of breath questionnaire and 
underwent street tests 6 minutes. The results 
of the history, physical examination, and 
functional capacity check (6MWT) are 
recorded in a special form for each subject 
with an identification number in each form. 
The degree of shortness of breath was 
measured from the scale of shortness of 
breath of MRC that was answered by the 
patient in the questionnaire guided by the 
meter. Functional capacity is measured from 
the maximum distance traveled by subjects in 
a 6 min (6MWD) walking test observed by 
the meter. Data were analyzed by using 
Shapiro-Wilk test to know the distribution of 
normal data or not because the sample is less 
than 50. When the data is normally 
distributed used one-way anova (parametric 
test) to analyze the correlation between 
degrees of breathlessness with result of 
distance of walking test 6 minute. When the 
data is not normally distributed, Kruskal-
Wallis test (non-parametric test) is used. The 
p value <0.05 is considered significant. 
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RESULT AND DISCUSSION 
 
Patients with tuberculosis who have done the 
therapy at least 6 months who have been 
declared cured by leaving a sequel seen from 
chest X-ray taken from Lung Polyclinic 
RSUP Dr. Sardjito and BP4 Yogyakarta in 
September 2013. The degree of shortness of 
breath was obtained from the completion of 
the MRC breathless questionnaire. Then, to 
find out the functional capacity, the patient 
underwent a 6 minute walking test. 
Previously, approval was obtained after the 
patient got an explanation. A total of 46 
patients have followed this study. But only 42 
patients were eligible after considering 
inclusion criteria. From the table it can be 
seen that most of the research subjects were 
patients with minimal shortness of breath 
(MRC scale 0). The result of lung function 
test also showed mean FVC of patient 
79.60% with standard deviation 21.70%, 
mean FEV1 patient 81.24% with standard 
deviation 17.34%, and mean FEV1 / FVC 
ratio 0.90 with standard deviation of 0.15. 
Shortness of breath in the 
respiratory system can be caused by 
respiratory diseases, chest wall disease, and 
pulmonary parenchymal disease (Longo, et 
al., 2012). Patients with sequelae may 
experience residual symptoms of respiratory 
lesions such as bronchiectasis, 
tracheobronchial stenosis, and 
broncholithiasis (Kim et al., 2001). Other 
remaining symptoms are chest wall lesions 
that include tuberculosis of the ribs, 
tuberculosis spondylitis, and malignancies 
associated with chronic empyema. In the 
pulmonary parenchyma, residual symptoms 
that may occur include tuberculoma, thin-
walled, sikatrik, end-stage lung damage, 
aspergilloma, and bronchogenic carcinoma 
(Kim et al. 2001). 
Table 1 Base characteristic of the Patient   
 
  Variable N % average±SB 
Gender, n (%)    
Male 28 66.7  
Female 14 33.3  
age   36.21±10.37 
Weight (Kg)   54.70±11.46 
Height (meters)   1.62±0.08 
Body mass indeks 
(kg/m2) 
  20.31±3.88 
-    < 18.5 12 28.6  
-    18.6 – 22.9 21 50  
-    > 23 9 21.4  
MRC scale, n (%)    
0 33 78.6  
1 5 11.9  
2 2 4.8  
3 2 4.8  
4 0 0  
6 minute MWD   257.02±64.56 
FVC (% prediction)   79.60±21.70 
FVC (L)   2.26±0.81 
FEV1 
(%prediction) 
  81.24±17.34 
FEV1 (L)   2.02±0.78 
Rasio FEV1/FVC   0.90±0.15 
Active smoker 12 28.6  
Ex-smoker 11 26.2  
Passive smoker 10 23.8  
Non-smoker 9 21.4  
 
Chest wall disease causes rigid chest 
wall conditions or weakened respiratory 
muscles which are later associated with 
increased effort to breathe (Longo, et al., 
2012). Disease in the pulmonary parenchyma 
is associated with decreased lung compliance, 
unequal ventilation or perfusion ratio, 
alveolar capillary interface defects that can 
cause hypoxemia and ultimately increase 
breathing desire.  
Assessment of the degree of 
breathlessness and functional capacity in 
patients was performed by filling the 
breathless scale of MRC and a 6-minute 
walking test. The shortness of breath scale of 
Acta Interna The Journal of Internal Medicine Vol. 6 No. 2 December 2016 
  Website Journal : http://jurnal.ugm.ac.id/jain 
 
 
73 
 
MRC is an indirect method for the 
measurement of shortness of breath (Callens, 
et al., 2009). This scale is the most commonly 
used validated scale for assessing shortness of 
breath in everyday life in patients with 
chronic respiratory pontitis (Launois, et al., 
2012). The shortness of breath scale of the 
MRC assesses the physical inability associated 
with shortness of breath by identifying 
shortness of breath that occurs when it 
should not (scale 0 and 1) and measuring the 
limitations of related body movements (2-4 
scales). There is a 98% agreement between 
researchers using this scale. This score also 
relates to other shortness of breath scale, 
lung function measurement, and direct 
measurement of physical disability such as 
walking distance (Stenton, 2008). Shortness 
of breath as measured by MRC dyspnea scale 
is a good predictor of walking distance 
(Marin, et al., 2001). 
Out of a total of 42 patients, various 
MRC scores were obtained. The most widely 
obtained were patients with MRC 0 scale of 
33 patients, followed by patients with MRC 1 
scale of 5 patients. There were only 2 patients 
on MRC 2 and 3, respectively, and no 
patients with MRC4 scale were present. 
 
Table 2 Result of MRC patient scale 
 
 Frequency Percentage 
Valid 0 33 78.6 
 1 5 11.9 
 2 2 4.8 
 3 2 4.8 
 Total 42 100.0 
 
 
 
 
Figure 1 Stem diagram of the patient’s MRC 
scale 
 
 
 
 
Figure 2 Scatter plot scale MRC with distance of 
6 minutes walking test with the distance of the 6-
minute test 
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Table 3 Average and standard deviation of 6-MWD 
on each MRC scale Mileage (meters) 
 
 mileage 
Average Standard deviation 
MRC 0 256.73 58.78 
 1 286.40 56.75 
 2 305.00 63.64 
 3 140.50 85.56 
 
 
Figure  3 Comparison of the mean distance of 6-
MWD 
 
 
Table 4 One-Way ANOVA MRC scale with 6 
minutes walking distance test 
6MWD Sum of 
Squares 
df Mean square F Sig. 
Between 
Groups 
36076.731 3 12025.577 3.390 .028* 
Within 
Groups 
134814.245 38 3547.743   
Total 170890.976 41    
 
In patients with MRC scales 0, the mean and 
standard deviations of the 6 minute walking 
distance were 256.73 ± 58.78, patients with 
MRC 1 scales were 286.40 ± 56.75, patients with 
MRC 2 scales were 305.00 ± 63.64, and patients 
with MRC 3 scales were 140.50 ± 85.56. There 
is an average increase of the scale of MRC 0 to 2 
and then decreases on the scale of MRC 3. 
 The data obtained in this study is 
normally distributed, known after the Shapiro-
Wilk test where p> 0,05. Because of normal data 
distribution, One-Way ANOVA is done and the 
p value is 0,028. From these results, it can be 
concluded that there is a relationship between 
the scale of breathlessness of MRC with distance 
of 6 minutes walking test because p <0.05. 
 
Table 5 Post hoc LSD analysis of MRC scale with 
average distance of 6 MWD 
 
(I) MRC (J) MRC Mean Difference 
(I-J) 
Sig. 
0 1 -29.67273 .306 
 2 -48.27273 .273 
 3 116.22727 .011* 
1 0 29.67273 .306 
 2 -18.60000 .711 
 3 145.90000 .006* 
2 0 48.27273 .273 
 1 18.60000 .711 
 3 164.50000 .009* 
3 0 -116.22727 .011* 
 1 -145.90000 .006* 
 2 -164.50000 .009* 
 
From the One-Way ANOVA we have 
done, we know that there is a significant 
difference between the mean mileage runs for 
each degree on the MRC scale. However, we do 
not know which pairs of MRC scales have 
significant differences in mean distance. 
Therefore, post hoc LSD analysis is done. From 
the above results, it can be seen that significant 
differences exist on the scale of MRC 0 and 3 
with a difference of 116.23, MRC 1 and 3 with a 
difference of 145.90, and MRC 2 and 3 scales 
with a difference of 164.50. 
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In normal people, the distance of a 6-
minute walking test ranges from 400 meters to 
700 meters (Enright, 2003). From the results of 
the distance of the 6-minute walking test in 
patients in the study, it can be seen that patients 
sekuele tuberculosis will experience a significant 
decrease in functional capacity seen from the 
distance traveled.  
The mean distance of a patient's 6-
minute walking test is 257.02 meters with 
standard deviation of 64.56 meters, which is 
below the normal limit. Few patients are able to 
achieve normal range of walking distance even 
with MRC 0 scale (minimal shortness of breath). 
Almost all patients have a walking distance of 
less than 400 m. This means that the sequelae of 
tuberculosis suffered by patients make the 
patient's functional capacity decrease. 
In theory, there should be a decrease in 
the distance traveled from the MRC scale 0 to 4. 
The results showed an increase in walking 
distance from patients with MRC scale 0-2, and 
then decreased in patients with MRC scale 3. 
The higher the patient's MRC scale, Decreases 
the distance traveled.  
There are many things that can affect 
why these results arise. The scale 0 and 1 on the 
MRC assess the shortness of breath that occurs 
when it should not appear. That is, patients with 
MRC scales 0 and 1 may experience shortness of 
breath but shortness of breath does not interfere 
with activity so that increased results on the 
graph can randomly occur. Then on a scale of 2-
4 there starts to be a disruption in the activity so 
that the distance of the patient's 6-minute 
walking test decreases (Stenton, 2008). 
Other reasons that may affect the above 
results are psychological effects such as 
motivated patients for activity and exercise, 
reduced depression, decreased fear of shortness 
of breath, and reported fewer episodes of 
breathlessness, thus improving the mileage of 
the walking test (Yoshida et al., 2006). 
Therefore, from the results of the study, it can 
be concluded that the distance of the 6-minute 
walking test will decrease in patients with severe 
shortness of breath with MRC 3 scale, but not 
too disturbing in mild cases such as in patients 
with MRC 0-2 scale On the graph actually 
increases. 
But the results in this study are still limited and 
need to be studied more deeply because of the 
smoking factor that can cause obstructive lung 
disease that can also cause shortness of breath. 
From the available data, it is known that 
12 (28.6%) patients are active smokers and 11 
(26.2%) patients are former smokers. Airway 
obstruction is one of the sequelae of pulmonary 
tuberculosis. Chronic obstructive pulmonary 
disease also often appears as a common 
comorbid in tuberculosis patients. Some of the 
existing literature supports the role of cigarettes 
in influencing the progression and clinical 
course of TB infection. However, without 
suffering from TB disease, smoking research 
subjects are at great risk for obstructive 
pulmonary disease that may cause shortness of 
breath (Chakrabarti, et, al., 2007). 
The design of this study is cross-
sectional, so researchers only do data retrieval 
and observation in one time only. Therefore, 
researchers can not keep up with the 
development of the patient's illness, so that the 
patient's lung condition before suffering TB can 
not be known. This may lead to a bias against 
the results of lung condition checks in patients 
with sequelae, whether worsening of pure 
pulmonary conditions due to the severity of TB 
disease or may have occurred prior to smoking-
induced tuberculosis. This is reinforced because 
most of the research subjects are smokers, while 
smokers themselves have a big risk to suffer 
from obstructive lung disease. 
 
CONCLUSION 
 
There was a correlation between degrees of 
breathlessness (MRC breathless scale) with 
Achadiono, Retnowulan, Nugroho 
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functional capacity (distance of 6-minute 
walking test) in patients with sequelae of 
pulmonary TB. 
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